Cargando…
Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
Over the past three decades, the incidence and prevalence of neuroendocrine tumors have gradually increased. Due to the slow-growing nature of these tumors, most cases are diagnosed at advanced stages. Prognosis and survival are associated with location of primary lesion, biochemical functional stat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723116/ https://www.ncbi.nlm.nih.gov/pubmed/29255345 http://dx.doi.org/10.2147/BTT.S108818 |